XENE - Xenon Pharmaceuticals Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue-3111,80315,577
Cost of Revenue23,63425,5731,1142,762
Gross Profit-23,634-25,26268912,815
Operating Expenses
Research Development23,63425,45318,71412,390
Selling General and Administrative8,3827,3136,7929,786
Non Recurring----
Others6,0006,0006,0006,000
Total Operating Expenses38,01632,88626,62024,938
Operating Income or Loss-38,016-32,575-24,817-9,361
Income from Continuing Operations
Total Other Income/Expenses Net3,5191,8711,820-6,391
Earnings Before Interest and Taxes-38,016-32,575-24,817-9,361
Interest Expense-1,394-1,394-1,394-1,394
Income Before Tax-34,497-30,704-22,997-15,752
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-34,497-30,704-22,997-15,752
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-34,497-30,704-22,997-15,752
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-31,616-30,704-22,997-15,752